A retrospective multicenter study assessing the association of disease progression pattern during third-line chemotherapy with Nivolumab with poor prognosis in advanced Gastric cancer
Latest Information Update: 01 Mar 2022
At a glance
- Drugs Antineoplastics (Primary) ; Nivolumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 01 Mar 2022 New trial record
- 22 Jan 2022 Results presented at the 2022 Gastrointestinal Cancers Symposium